Presence and regulation of epithelial sodium channels in the marginal cells of stria vascularis.
CONCLUSIONS
This study indicates that epithelial Na(+)-selective channels (ENaC) recycle Na(+) via clathrin-mediated endocytosis in the marginal cells of the stria vascularis and that clathrin-independent endocytosis appeared to be modulated by the amount of Na(+) transported. These results suggest the presence of ENaC in the luminal membrane of marginal cells and that ENaC are an efficient pathway for the uptake of Na(+) from the endolymph.


OBJECTIVE
The ENaC found in many transporting epithelia play a key role in the regulation of salts and water homeostasis, cellular pH, cell volume, and cell function. Both biochemical and physiological approaches have been used to identify, characterize, and quantify this important channel, but its location in the marginal cells of the stria vascularis has not been fully clarified. The aim of this study was to determine the localization and regulation of ENaC.


METHODS
Forty healthy female guinea pigs were used: 20 for the control experiment, 10 for the amiloride experiment, and 10 for the aldosterone experiment. We perfused cationized ferritin (CF) and microperoxidase (MPO) as tracers for clathrin-mediated and clathrin-independent endocytosis, respectively, into the cochlear duct. After 30 min of endolymphatic perfusion, the tissues were fixed and CF- and MPO-loaded endosomes within the marginal cell were observed by transmission electron microscopy. The numbers of CF- and MPO-loaded endosomes were compared between the three groups.


RESULTS
In the amiloride group, the numbers of CF- and MPO-loaded endosomes decreased in comparison with the control. In the aldosterone group, the numbers of CF- and MPO-loaded endosomes decreased and increased, respectively. Recently, it has been reported that ENaC are endocytosed via clathrin-mediated endosomes and aldosterone decreases the rate of endocytosis of ENaC. In this study, the results of the aldosterone experiment were consistent with those of recent studies.
Kakigi
Akinobu
A
Department of Otolaryngology, Kochi Medical School, Kochi, Japan. kakgia@med.kochi-u.ac.jp
Okada
Teruhiko
T
Takeda
Taizo
T
Taguchi
Daizo
D
Nishioka
Rie
R
D000450:Aldosterone / Q000494:pharmacology; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D002966:Clathrin / Q000502:physiology; D022163:Clathrin-Coated Vesicles / Q000502:physiology / Q000648:ultrastructure; D004705:Endocytosis / Q000187:drug effects / Q000502:physiology*; D004710:Endolymph / Q000502:physiology; D011992:Endosomes / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D053503:Epithelial Sodium Channels / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D005260:Female; D006168:Guinea Pigs; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D046529:Microscopy, Electron, Transmission; D012964:Sodium / Q000378:metabolism*; D013316:Stria Vascularis / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure
D002966:Clathrin; D053503:Epithelial Sodium Channels; D000450:Aldosterone; D000584:Amiloride; D012964:Sodium